InsiderClue
Stocks · Health care · Pharmaceutical Preparations

KAMADA LTD

KMDA Clue Score68
Israel Fiscal year ends December CIK 0001567529
$8.08 +3.92% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $8.08 +55.09% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue77.5Operating income−5.5Net income−6.7EPS, diluted−0.18Fiscal year 2017Revenue102.8 +32.7%Operating income7.4Net income6.9EPS, diluted0.18Fiscal year 2018Revenue114.5 +11.3%Operating income19.3Net income22.3 +223.1%EPS, diluted0.55 +205.6%Fiscal year 2019Revenue127.2 +11.1%Operating income22.8Net income22.3 −0.2%EPS, diluted0.55 +0.0%Fiscal year 2020Revenue133.2 +4.8%Operating income19.2Net income17.1 −23.0%EPS, diluted0.38 −30.9%Fiscal year 2021Revenue103.6 −22.2%Operating income−0.7Net income−2.2 −113.0%EPS, diluted−0.05 −113.2%Fiscal year 2022Revenue129.3 +24.8%Operating income4.5Net income−2.3EPS, diluted−0.05Fiscal year 2023Revenue142.5 +10.2%Operating income10.1Net income8.3EPS, diluted0.15Fiscal year 2024Revenue161.0 +12.9%Operating income20.1Net income14.5 +74.6%EPS, diluted0.25 +66.7%Fiscal year 2025Revenue180.5 +12.1%Operating income26.2Net income20.2 +39.7%EPS, diluted0.35 +40.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 77.5 102.8 114.5 127.2 133.2 103.6 129.3 142.5 161.0 180.5
Growth +32.7% +11.3% +11.1% +4.8% −22.2% +24.8% +10.2% +12.9% +12.1%
Operating income −5.5 7.4 19.3 22.8 19.2 −0.7 4.5 10.1 20.1 26.2
Net income −6.7 6.9 22.3 22.3 17.1 −2.2 −2.3 8.3 14.5 20.2
Growth +223.1% −0.2% −23.0% −113.0% +74.6% +39.7%
EPS, diluted −0.18 0.18 0.55 0.55 0.38 −0.05 −0.05 0.15 0.25 0.35
Growth +205.6% +0.0% −30.9% −113.2% +66.7% +40.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin27.6%Operating margin−7.1%Net margin−8.7%Fiscal year 2017Gross margin31.2%Operating margin7.2%Net margin6.7%Fiscal year 2018Gross margin36.2%Operating margin16.8%Net margin19.5%Fiscal year 2019Gross margin39.1%Operating margin17.9%Net margin17.5%Fiscal year 2020Gross margin35.7%Operating margin14.4%Net margin12.9%Fiscal year 2021Gross margin29.3%Operating margin−0.7%Net margin−2.2%Fiscal year 2022Gross margin36.1%Operating margin3.5%Net margin−1.8%Fiscal year 2023Gross margin38.9%Operating margin7.1%Net margin5.8%Fiscal year 2024Gross margin43.5%Operating margin12.5%Net margin9.0%Fiscal year 2025Gross margin42.3%Operating margin14.5%Net margin11.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 27.6% 31.2% 36.2% 39.1% 35.7% 29.3% 36.1% 38.9% 43.5% 42.3%
Operating margin −7.1% 7.2% 16.8% 17.9% 14.4% −0.7% 3.5% 7.1% 12.5% 14.5%
Net margin −8.7% 6.7% 19.5% 17.5% 12.9% −2.2% −1.8% 5.8% 9.0% 11.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2016Operating cash flow1.9Fiscal year 2017Operating cash flow3.6Fiscal year 2018Operating cash flow10.5Fiscal year 2019Operating cash flow27.6Fiscal year 2020Operating cash flow19.1Fiscal year 2021Operating cash flow−8.8Fiscal year 2022Operating cash flow28.6Fiscal year 2023Operating cash flow4.3Fiscal year 2024Operating cash flow47.6Fiscal year 2025Operating cash flow25.5Dividends paid−11.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 1.9 3.6 10.5 27.6 19.1 −8.8 28.6 4.3 47.6 25.5
Dividends paid n/a n/a n/a n/a n/a n/a n/a n/a n/a −11.5

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash10.0Total debt2.2Net cash (debt)7.8Shareholders’ equity66.7Debt to equity0.03Fiscal year 2017Cash12.7Total debt2.6Net cash (debt)10.1Shareholders’ equity89.5Debt to equity0.03Fiscal year 2018Cash18.1Total debt1.1Net cash (debt)17.0Shareholders’ equity112.4Debt to equity0.01Fiscal year 2019Cash42.7Total debt1.2Net cash (debt)41.4Shareholders’ equity135.3Debt to equity0.01Fiscal year 2020Cash70.2Total debt0.5Net cash (debt)69.7Shareholders’ equity178.6Debt to equity0.00Fiscal year 2021Cash18.6Total debt22.7Net cash (debt)−4.1Shareholders’ equity176.8Debt to equity0.13Fiscal year 2022Cash34.3Total debt21.9Net cash (debt)12.4Shareholders’ equity176.0Debt to equity0.12Fiscal year 2023Cash55.6Total debt15.0Net cash (debt)40.6Shareholders’ equity244.0Debt to equity0.06Fiscal year 2024Cash78.4Total debt10.2Net cash (debt)68.3Shareholders’ equity259.5Debt to equity0.04Fiscal year 2025Cash75.5Total debt9.9Net cash (debt)65.5Shareholders’ equity269.1Debt to equity0.04
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 10.0 12.7 18.1 42.7 70.2 18.6 34.3 55.6 78.4 75.5
Total debt 2.2 2.6 1.1 1.2 0.5 22.7 21.9 15.0 10.2 9.9
Net cash (debt) 7.8 10.1 17.0 41.4 69.7 −4.1 12.4 40.6 68.3 65.5
Shareholders’ equity 66.7 89.5 112.4 135.3 178.6 176.8 176.0 244.0 259.5 269.1
Debt to equity 0.03 0.03 0.01 0.01 0.00 0.13 0.12 0.06 0.04 0.04

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
77.5 102.8 114.5 127.2 133.2 103.6 129.3 142.5 161.0 180.5
Growth +32.7% +11.3% +11.1% +4.8% −22.2% +24.8% +10.2% +12.9% +12.1%
56.1 70.7 73.0 77.5 85.7 73.3 82.6 87.0 91.0 104.1
21.4 32.1 41.5 49.7 47.6 30.3 46.7 55.5 70.0 76.4
Growth +50.2% +29.2% +19.9% −4.4% −36.2% +54.0% +18.8% +26.1% +9.2%
16.2 12.0 9.7 13.1 13.6 11.4 13.2 13.9 15.2 13.0
n/a n/a n/a 9.2 10.1 0.3 1.8 14.4 15.7 18.7
−5.5 7.4 19.3 22.8 19.2 −0.7 4.5 10.1 20.1 26.2
Growth +158.7% +18.3% −15.6% −103.6% +122.1% +99.2% +30.8%
−5.0 7.2 20.3 23.0 18.6 −1.9 −2.3 8.4 13.3 23.5
1.7 0.3 −2.0 0.7 1.4 0.3 0.1 0.1 −1.1 3.3
−6.7 6.9 22.3 22.3 17.1 −2.2 −2.3 8.3 14.5 20.2
Growth +223.1% −0.2% −23.0% −113.0% +74.6% +39.7%
Per share
−0.18 0.18 0.55 0.55 0.39 −0.05 −0.05 0.17 0.25 0.35
−0.18 0.18 0.55 0.55 0.38 −0.05 −0.05 0.15 0.25 0.35
Growth +205.6% +0.0% −30.9% −113.2% +66.7% +40.0%
36.4 38.0 40.3 40.3 44.1 44.8 44.8 48.8 57.5 57.6
36.4 38.0 40.4 40.6 44.6 44.9 44.9 53.7 57.8 58.3
Growth +4.5% +6.3% +0.3% +9.9% +0.7% −0.1% +19.7% +7.7% +0.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 6.3% a year over five years, and earnings per share fell 1.6% a year.
  • The diluted share count rose 30.8% in five years, which is dilution.
  • Operating margin is flat at 14.5%.
  • A net loss in 3 of 10 years on file.